Related Experiment Video
Updated: Jun 14, 2025

12:00
Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
Published on: January 22, 2015
12.4K
Drug Loading in Chitosan-Based Nanoparticles.
Yedi Herdiana1, Ellin Febrina2, Siti Nurhasanah3
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.
Pharmaceutics
|August 29, 2024
Summary
Chitosan nanoparticles (CSNPs) offer enhanced drug delivery with improved bioavailability and reduced toxicity. This review highlights strategies for developing CSNPs with high drug loading capacity, addressing a key challenge in nanomedicine.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Chitosan nanoparticles (CSNPs) are biodegradable, biocompatible, and low-toxicity drug delivery vehicles.
- Encapsulating drugs in nanoparticles (NPs) enhances bioavailability, minimizes side effects, and enables controlled release and targeted delivery.
- Low drug loading capacity is a significant challenge for current nanoparticle systems.
Purpose of the Study:
- To review recent advancements in developing CSNPs with high drug loading capacity.
- To summarize synthesis strategies for creating effective CSNP-based drug delivery systems.
- To provide guidelines for future CSNP development.
Main Methods:
- Literature review of recent research on CSNP synthesis and drug delivery applications.
- Analysis of various CSNP systems, materials, and drugs.
- Examination of synthesis methods, drug loading, encapsulation efficiency, release profiles, and stability.
Main Results:
- CSNPs demonstrate potential for targeted and controlled drug release.
- Various synthesis strategies exist for improving drug loading in CSNPs.
- Factors influencing drug loading efficiency have been identified.
Conclusions:
- CSNPs are promising for advanced drug delivery, but optimizing drug loading remains crucial.
- Further research into synthesis strategies can enhance CSNP efficacy.
- This review offers insights for developing next-generation CSNP drug delivery systems.

